(Allergan plc)

	AGN latest price $185.8423 (-0.13%) ($185.3404 - $189.1142) on Mon. Dec. 19, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.16% (three month average)
RSI	49
Latest Price	$185.8423(-0.13%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.2% a day on average for past five trading days.
Weekly Trend	AGN advances 0.4% a week on average for past two weeks.
Market Behavior	Growth stock rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(44%)    SPY(43%)    VT(43%)
Factors Impacting AGN price	AGN will decline at least -1.08% in a week (0% probabilities).   VIXM(-29%)    TLT(-15%)    UUP(-14%)    SHY(-3%)    IPO(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.08% (StdDev 2.16%)
Hourly BBV	0 ()
Intraday Trend	-0.6%

5 Day Moving Average	$186.03(-0.1%)
10 Day Moving Average	$184.97(0.47%)
20 Day Moving Average	$184.82(0.55%)
To recent high	-21.5%
To recent low	2.2%
Market Cap	$61.272b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed